For Eric Lefkofsky, philanthropy is business as usual

Eric Lefkofsky is a billionaire entrepreneur who not only financially endows philanthropic endeavors but also builds good works into his business models. Currently residing in Glencoe, Illinois, Mr. Lefkofsky focuses a majority of his efforts in the Chicago area. His corporate reach is, however, global and substantial.

 

Mr. Lefkofsky concentrates his endowments on education, arts and culture, human rights, healthcare, and medical research organizations. In the Chicago area, he is Chairman of the Board of Trustees of the Steppenwolf Theatre Company and a Trustee of Lurie Children’s Hospital of Chicago, The Art Institute of Chicago, The Museum of Science and Industry and World Business Chicago according to his LinkedIn profile. Outside Chicago, Mr. Lefkofsky donates to several hospitals, associations and education programs according to the Inside Philanthropy Guide. He is a signatory of the Giving Pledge, a directive established by Mr. and Mrs. Bill Gates and Warren Buffett for billionaires committed to donating most of their wealth to charity. Additionally, Mr. Lefkofsky operates the Lefkofsky Family Foundation to further support scientific and educational initiatives aimed at enhancing the quality of life.  See also www.crunchbase.com.

 

Mr. Eric Lefkofsky’s generous nature extends beyond nonprofit foundations into the companies he builds. Three examples are Uptake, Lightbank and Tempus, Inc. Uptake benefits global start-up companies by supplying cross-industry data useful in designing and decision making. This extensive, comprehensive database leads to safer, more productive, more efficient companies with less asset loss and less chance of catastrophic failure. The Lightbank.com is a venture capital firm that specializes in backing disruptive technology. As defined by McKinsey and Company, disruptive technology involves innovation that significantly changes or replaces conventional methods for the better. For example, robotic surgery and sustainable energy production are disruptive technologies. Finally, Tempus is a technology company serving the cancer treatment field by amassing a comprehensive, cohesive database of treatments cross-referenced with outcomes, patient medical histories and even genomic sequencing services. This database is available in real-time to assist physicians in choosing and tailoring treatment options for each patient.  Check https://www.tempus.com/about-us/

 

Mr. Eric Lefkofsky shares his vision with his wife, Liz, and his longtime business partner Brad Keywell.